↓ Skip to main content

Dove Medical Press

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, October 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
118 Mendeley
Title
12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus
Published in
Clinical Pharmacology : Advances and Applications, October 2018
DOI 10.2147/cpaa.s164785
Pubmed ID
Authors

Simone Perna, Manuela Mainardi, Paolo Astrone, Carlotta Gozzer, Anna Biava, Ruben Bacchio, Daniele Spadaccini, Sebastiano Bruno Solerte, Mariangela Rondanelli

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 118 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 17%
Student > Master 17 14%
Student > Bachelor 14 12%
Student > Ph. D. Student 8 7%
Student > Postgraduate 6 5%
Other 15 13%
Unknown 38 32%
Readers by discipline Count As %
Medicine and Dentistry 44 37%
Pharmacology, Toxicology and Pharmaceutical Science 12 10%
Nursing and Health Professions 3 3%
Biochemistry, Genetics and Molecular Biology 3 3%
Psychology 3 3%
Other 10 8%
Unknown 43 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2021.
All research outputs
#17,490,079
of 25,655,374 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#117
of 179 outputs
Outputs of similar age
#228,555
of 355,535 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#2
of 5 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 179 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,535 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.